Hiroshi Tateishi

Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases

Aliaa M. Mohassab, Heba A. Hassan, Dalia Abdelhamid et al. · Bioorganic Chemistry · 2020 · 114 citations

Pharmacy, Medicinal Chemistry, Oncology +14

In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors

Belgin Sever, Mehlika Dilek Altıntop, Ahmet Özdemır et al. · Molecules · 2020 · 51 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

A clue to unprecedented strategy to HIV eradication: “Lock-in and apoptosis”

Hiroshi Tateishi, Kazuaki Monde, Kensaku Anraku et al. · Scientific Reports · 2017 · 50 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +17

The First Pentacyclic Triterpenoid Gypsogenin Derivative Exhibiting Anti-ABL1 Kinase and Anti-chronic Myelogenous Leukemia Activities

Halil I. Ciftci, Safiye Emirdağ, Taha F. S. Ali et al. · Biological and Pharmaceutical Bulletin · 2018 · 49 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

EGFR-Targeted Pentacyclic Triterpene Analogues for Glioma Therapy

Halil I. Ciftci, Mohamed O. Radwan, Belgin Sever et al. · International Journal of Molecular Sciences · 2021 · 33 citations · Full text

Medicine, Medicinal Chemistry, Oncology +17